门冬胰岛素30联合阿卡波糖对初诊2型糖尿病胰岛功能的影响  

Insulin Aspart 30 Combined Acarbose in Newly Diagnosed Type 2 Diabetes Islet Function

作　　者：符文耀[1] 

机构地区：[1]南阳市第一人民医院内分泌科,473000

出　　处：《中国继续医学教育》2015年第12期174-175,共2页China Continuing Medical Education

摘　　要：目的：探讨采用门冬胰岛素30联合阿卡波糖治疗初诊2型糖尿病后患者胰岛功能的变化。方法随机选取我院2012年11月～2014年9月期间收治的初诊2型糖尿病患者47例，采用门冬胰岛素30联合阿卡波糖对患者进行治疗，对治疗前后患者血糖水平、胰岛素β细胞功能的变化情况进行观察。结果患者经治疗后，其胰岛素分泌明显。Objective Investigate islet function in patients using insulin aspart 30 combined after acarbose therapy in newly diagnosed type 2 diabetes.MethodsRandomly selected in our hospital in November 2012 -2014 period September diagnosed 47 cases of type 2 diabetes, insulin aspart 30 combined use of acarbose treatment of patients, blood glucose levels before and after treatment in patients with insulin β-cell function the changes were observed.Results Patients after treatment, signiifcantly increased insulin secretion, IR decreased, IS significantly increased, the difference was significant （P〈0.05）.Conclusion Using insulin aspart 30 combined acarbose therapy in newly diagnosed type 2 diabetes, the effect is signiifcant, can effectively promote the recovery of patients with pancreatic islet cell function and control blood sugar levels, it is recommended to further promote in clinical practice.

关 键 词：初诊2型糖尿病 门冬胰岛素30 阿卡波糖 胰岛功能 INSULIN ASPART 30 

分 类 号：R587.1[医药卫生—内分泌]